文献速递帕金森病与运动障碍认知障碍与痴呆

快速眼动睡眠行为障碍中表型转化的危险因素

Risk Factors for Phenoconversion in Rapid Eye Movement Sleep Behavior Disorder.
PubMed 文献 · Ann Neurol · 2022-01-24

该多中心队列研究对319例特发性/孤立性快速眼动睡眠行为障碍(iRBD)患者进行基线环境与生活方式问卷调查,并前瞻性随访11年。平均随访5.8年后,281例有随访信息的患者中130例(46.3%)发生神经退行性疾病;3年、6年、10年累积转化率分别为24.2%、44.8%、67.5%。高龄和硝酸酯衍生物使用与转化风险升高相关,而农药暴露史、农村居住、降脂药物使用和呼吸系统药物使用与转化风险降低相关。

要点

  • iRBD患者平均随访5.8年,46.3%发生帕金森病或痴呆。
  • 高龄(aHR=1.05)和硝酸酯衍生物使用(aHR=2.18)增加转化风险。
  • 农药暴露史、农村居住、降脂药和呼吸系统药物使用与转化风险降低相关。

核心结论

  • 研究结果阐明了环境因素和共病情况在识别iRBD患者中表型转化高风险个体方面的预测价值。

研究设计与样本

  • 多中心队列研究,纳入来自12个中心的特发性/孤立性快速眼动睡眠行为障碍(iRBD)患者,基线时通过标准化问卷详细评估潜在的环境和生活方式危险因素,随后进行前瞻性随访并评估帕金森病或痴呆,采用竞争风险分析估计累积发生率,采用Cox回归分析评估环境/生活方式因素的预测价值,随访期11年,校正年龄、性别和中心。

主要发现

  • 319例无帕金森病或痴呆的患者中,281例提供了随访信息;平均随访5.8年后,130例(46.3%)发生神经退行性疾病。
  • 总体表型转化率在3年后为24.2%,6年后为44.8%,10年后为67.5%。
  • 高龄(校正风险比[aHR]=1.05)和硝酸酯衍生物使用(aHR=2.18)的患者更可能发生表型转化。
  • 既往农药暴露(aHR=0.21-0.64)、农村居住(aHR=0.53)、降脂药物使用(aHR=0.59)和呼吸系统药物使用(aHR=0.36)与较低的表型转化风险相关。
  • 转化为原发性痴呆和帕金森病的危险因素总体相似,其中痴呆首发的转化者咖啡摄入和β受体阻滞剂摄入较低,痴呆家族史发生率较高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study was undertaken to follow up predictive factors for α-synuclein-related neurodegenerative diseases in a multicenter cohort of idiopathic/isolated rapid eye movement sleep behavior disorder (iRBD). METHODS: Patients with iRBD from 12 centers underwent a detailed assessment for potential environmental and lifestyle risk factors via a standardized questionnaire at baseline. Patients were then prospectively followed and received assessments for parkinsonism or dementia during follow-up. The cumulative incidence of parkinsonism or dementia was estimated with competing risk analysis. Cox regression analyses were used to evaluate the predictive value of environmental/lifestyle factors over a follow-up period of 11 years, adjusting for age, sex, and center. RESULTS: Of 319 patients who were free of parkinsonism or dementia, 281 provided follow-up information. After a mean follow-up of 5.8 years, 130 (46.3%) patients developed neurodegenerative disease. The overall phenoconversion rate was 24.2% after 3 years, 44.8% after 6 years, and 67.5% after 10 years. Patients with older age (adjusted hazard ratio [aHR] = 1.05) and nitrate derivative use (aHR = 2.18) were more likely to phenoconvert, whereas prior pesticide exposure (aHR = 0.21-0.64), rural living (aHR = 0.53), lipid-lowering medication use (aHR = 0.59), and respiratory medication use (aHR = 0.36) were associated with lower phenoconversion risk. Risk factors for those converting to primary dementia and parkinsonism were generally similar, with dementia-first converters having lower coffee intake and beta-blocker intake, and higher occurrence of family history of dementia. INTERPRETATION: Our findings elucidate the predictive values of environmental factors and comorbid conditions in identifying RBD patients at higher risk of phenoconversion. ANN NEUROL 2022;91:404-416.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Zhang H, Iranzo A, Högl B, et al. Risk Factors for Phenoconversion in Rapid Eye Movement Sleep Behavior Disorder. Ann Neurol. 2022. PMID: 34981563. doi:10.1002/ana.26298

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。